BioMérieux S.A.
BIM
株式のランク
#1851
bioMérieux S.A. is a global entity operating across the Americas, Europe, the... bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
株価
$97.31
時価総額
$11.45B
変化（1日）
-5.92%
変化（1年）
-23.81%
国
FR
取引 BioMérieux S.A. (BIM)
カテゴリー
Healthcare
BioMérieux S.A.（BIM）の収益
Jun 2026 時点の収益 TTM: $4.73B
BioMérieux S.A. の最新の財務報告によると、現在の収益 (TTM) は $4.73B です。2023 年には $4.06B の収益があり、これは 2022 年の $3.85B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
BioMérieux S.A. の収益履歴（2005 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $4.73B | 14.30% |
| 2024 | $4.14B | 1.95% |
| 2023 | $4.06B | 5.51% |
| 2022 | $3.85B | 0.28% |
| 2021 | $3.84B | 1.10% |
| 2020 | $3.80B | 26.54% |
| 2019 | $3.00B | 7.86% |
| 2018 | $2.78B | 1.34% |
| 2017 | $2.75B | 24.07% |
| 2016 | $2.21B | 3.74% |
| 2015 | $2.13B | 3.81% |
| 2014 | $2.05B | -5.89% |
| 2013 | $2.18B | 5.45% |
| 2012 | $2.07B | 12.08% |
| 2011 | $1.85B | 1.83% |
| 2010 | $1.81B | 3.43% |
| 2009 | $1.75B | 13.35% |
| 2008 | $1.55B | -0.38% |
| 2007 | $1.55B | 13.87% |
| 2006 | $1.36B | 16.21% |
| 2005 | $1.17B | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $46.34B | 878.90% |
US
|
|
| $25.11B | 430.41% |
US
|
|
| $2.71B | -42.81% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 55.74% |
US
|
